InvestorsHub Logo
Followers 75
Posts 7486
Boards Moderated 0
Alias Born 04/18/2006

Re: Kenimous post# 53199

Saturday, 01/07/2017 12:21:10 PM

Saturday, January 07, 2017 12:21:10 PM

Post# of 195074
I beg to differ. The company does care about the share price otherwise why would they ever spend the cash required to do quarterly reviews and a full audit of financials to uplist off of the pinks. Goal of mananagement is to improve the standing of this stock beyond the OTC, they did make some poor choices with shares for services that doesn't appear to have paid off for share price, but it did improve share price just not for the most recent shareholders, cleared debt, and now it has settled, but anyone who has patience will be rewarded in 2017 and much more beyond that.

I like how some try to spit on 30% net revenue growth. They do that again next year and we are at 25 million net revenue. Do you know how hard that is in our competitive sector. The margins were smaller because we offer services no other pharmacies offer that has spurred that growth. That's why they started Smart Medical Alliance, that is the division of Progressive that offers extra services that we were providing for free that they are now charging a fee for services for. If profitability comes from this then they will have been successful on capitalizing on this and increasing operating profits.

Management does need to curtail shares for services in the future. Chicago Ventures in my opinion will never receive a share of RXMD unless we complete a M&A. Here's to 2017. Cheers RXMD investors and good luck to you all.

"To Give Anything Less Than Your Best, Is To Sacrifice the Gift." - Steve Prefontaine

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RXMD News